SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-028708
Filing Date
2017-05-19
Accepted
2017-05-19 19:02:47
Documents
2
Period of Report
2017-05-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v467541_form3.html 3  
1 OWNERSHIP DOCUMENT v467541_form3.xml 3 3250
2 EXHIBIT 24 v467541_ex24.htm EX-24 6994
  Complete submission text file 0001144204-17-028708.txt   11726
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O SORRENTO THERAPEUTICS, INC. 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address
Ferrigno Dean (Reporting) CIK: 0001707226 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36150 | Film No.: 17859450